Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by sweenbyon Nov 04, 2010 12:42pm

218 Views

Post# 17657828

Looking good

Most Recent Trades
Time	Price	Change	#Shares	Buyer	Seller
12:26:18	0.465	0.085	300	89 Raymond James	85 Scotia
12:26:18	0.465	0.085	10,000	80 National Bank	44 Jones Gable
12:26:18	0.46	0.08	5,000	80 National Bank	2 RBC
12:26:18	0.45	0.07	16,000	80 National Bank	85 Scotia
12:26:18	0.445	0.065	10,000	80 National Bank	19 Desjardins
12:26:18	0.43	0.05	5,500	80 National Bank	80 National Bank
12:14:49	0.42	0.04	2,500	80 National Bank	15 UBS
11:35:52	0.42	0.04	2,500	9 BMO Nesbitt	15 UBS
11:31:41	0.42	0.04	10,000	7 TD Sec	15 UBS
11:31:41	0.42	0.04	5,000	7 TD Sec	19 Desjardins